Unilife Corporation fka UNISQ

[difumetti]

Jefferies Downgrades Unilife to Hold

Brokerage firm Jefferies Downgrades its rating on Unilife(NASDAQ:UNIS). The shares have been rated Hold. Previously, the analysts had a Buy rating on the counter. The rating by Jefferies was issued on Aug 6, 2015.

Unilife Corporation (UNIS): 5 Brokerage firm Analysts have agreed with the mean estimate for the short term price target of $9.55 in Unilife Corporation (UNIS). However, the stock price could fluctuate by $ 3.58 from the estimate as it is suggested by the standard deviation reading. The higher estimate has been put at $16 price target with the lower price estimate is calculated at $6 Unilife Corporation has lost 9.84% in the last five trading days and dropped 19.51% in the last 4 weeks. Unilife Corporation has dropped 49.7% during the last 3-month period . Year-to-Date the stock performance stands at -50.75%.

Currently the company Insiders own 1.2% of Unilife Corporation Company shares. In the past six months, there is a change of -2.14% in the total insider ownership. Institutional Investors own 40.3% of Company shares. During last 3 month period, 0.43% of total institutional ownership has changed in the company shares. On a different note, The Company has disclosed insider buying and selling activities to the Securities Exchange, The officer (See Remarks), of Unilife Corp, Pyers Dennis had unloaded 17,349 shares at $3.08 per share in a transaction on May 14, 2015. The total value of transaction was $53,435. The Insider information was revealed by the Securities and Exchange Commission in a Form 4 filing.

Unilife Corporation (UNIS) : On Tuesday heightened volatility was witnessed in Unilife Corporation (UNIS) which led to swings in the share price. The shares opened for trading at $1.61 and hit $1.6699 on the upside , eventually ending the session at $1.65, with a gain of 2.48% or 0.04 points. The heightened volatility saw the trading volume jump to 1,335,929 shares. The 52-week high of the share price is $4.9 and the company has a market cap of $217 million. The 52-week low of the share price is at $1.59 .

Unilife Corporation (Unilife) is a developer, manufacturer and supplier of injectable drugs delivery systems. The Company manufactures and supplies its devices to pharmaceutical companies in a format where they can be filled and packaged with an injectable therapy prior to its shipment to the end-user. The Company’s technology platforms cover six device categories: Prefilled Syringes, Drug Reconstitution Delivery Systems, Auto-Injectors, Wearable Injectors, Ocular Delivery Systems and Delivery Systems.